Nuclear trafficking of macromolecules by an oligopeptide derived from Vpr of human immunodeficiency virus type-1

Biochemical and Biophysical Research Communications

Volumn 320, Issue 1, 2004, Pages 18-26

  Taguchi, Takashi ^a   Shimura, Mari ^a   Osawa, Yoshiaki ^a   Suzuki, Yasunori ^a   Mizoguchi, Izuru ^a   Niino, Koitsu ^b   Takaku, Fumimaro ^c   Ishizaka, Yukihito ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b Niino Clinic   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

HIV 1; Nuclear trafficking; Protein transduction domain; Resting cells; Vpr

Indexed keywords

AMINO ACID; BETA GALACTOSIDASE; OLIGOPEPTIDE; TRANSACTIVATOR PROTEIN; VPR PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROMOLECULE; MOLECULAR DYNAMICS; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STAINING; UMBILICAL CORD BLOOD;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; GENE PRODUCTS, VPR; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 2942669888     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.126     Document Type: Article

References (30)

1. Wong-Staal F., Chanda P.K., Ghrayeb J. Human immunodeficiency virus: the eighth gene. AIDS Res. Hum. Retroviruses. 3:1987;33-39
2. Cohen E.A., Subbramanian R.A., Göttlinger H.G. Role of auxiliary proteins in retroviral morphogenesis. Curr. Top. Microbiol. Immunol. 214:1996;219-235
3. Yu X.F., Matsuda M., Essex M., Lee T.H. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J. Virol. 64:1990;5688-5693
4. Paxton W., Connor R.I., Landau N.R. Incorporation of vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 67:1993;7229-7237
5. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64:1990;3097-3099
6. Vodicka M.A., Koepp D.M., Silver P.A., Emerman M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12:1998;175-185
7. Henklein P., Bruns K., Sherman M.P., Tessmer U., Licha K., Kopp J., de Noronha C.M.C., Greene W.C., Wray V., Schubert U. Functional and structural characterization of synthetic HIV-1 Vpr that transduces cells, localizes to the nucleus, and induces G2 cell cycle arrest. J. Biol. Chem. 275:2000;32016-32026
8. Jenkins Y., McEntee M., Weis K., Greene W.C. Characterization of HIV-1 vpr nuclear import: analysis of signals and pathways. J. Cell Biol. 143:1998;875-885
9. Shimura M., Tanaka Y., Nakamura S., Minemoto Y., Yamashita K., Hatake K., Takaku F., Ishizaka Y. Micronuclei formation and aneuploidy induced by Vpr, an accessory gene of human immunodeficiency virus type 1. FASEB J. 13:1999;621-637
10. Shimura M., Onozuka Y., Yamaguchi T., Hatake K., Takaku F., Ishizaka Y. Micronuclei formation with chromosome breaks and gene amplification caused by Vpr, an accessory gene of human immunodeficiency virus. Cancer Res. 59:1999;2259-2264
11. Levy D.N., Refaeli Y., MacGregor R.R., Weiner D.B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 91:1994;10873-10877
12. Levy D.N., Refaeli Y., Weiner D.B. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69:1995;1243-1252
13. Huang M.-B., Weeks O., Zhao L.-J., Saltarelli M., Bond V.C. Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J. Neurovirol. 6:2000;202-220
14. Kichler A., Pages J.C., Leborgne C., Druillennec S., Lenoir C., Coulaud D., Delain E., Le Cam E., Roques B.P., Danos O. Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R. J. Virol. 74:2000;5424-5431
15. Sherman M.P., Schubert U., Williams S.A., de Noronha C.M.C., Kreisberg J.F., Henklein P., Greene W.C. HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology. 302:2002;95-105
16. Piller S.C., Ewart G.D., Premkumar A., Cox G.B., Gage P.W. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc. Natl. Acad. Sci. USA. 93:1996;111-115
17. Piller S.C., Ewart G.D., Jans D.A., Gage P.W., Cox G.B. The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J. Virol. 73:1999;4230-4238
18. Console S., Marty C., Garcia-Echeverria C., Schwendener R., Ballmer-Hofer K. Antennapedia and HIV transactivator of transcription (TAT) protein transduction domains promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J. Biol. Chem. 278:2003;35109-35114
19. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:1997;223-233
20. Caron N.J., Torrente Y., Camirand G., Bujold M., Chapdelaine P., Leriche K., Bresolin N., Tremblay J.P. Intracellular delivery of a Tat-eGFP fusion protein into muscle cells. Mol. Ther. 3:2001;310-318
21. Yano L., Shimura M., Taniguchi M., Hayashi Y., Suzuki T., Hatake K., Takaku F., Ishizaka Y. Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinase. Hum. Gene Ther. 11:2000;995-1004
22. Sambrook J., Russell D.W. Molecular Cloning: A Laboratory Manual. 2001;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
23. Morris M.C., Depollier J., Mery J., Heitz F., Divita G. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19:2001;1173-1176
24. Popov S., Rexach M., Zybarth G., Reiling N., Lee M.A., Ratner L., Lane C.M., Moore M.S., Blobel G., Bukrinsky M. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17:1998;909-917
25. Vodicka M.A. Determinants for lentiviral infection of non-dividing cells. Somat. Cell Mol. Genet. 26:2001;35-49
26. Popov S., Rexach M., Ratner L., Blobel G., Bukrinsky M. Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 273:1998;13347-13352
27. Fouchier R.A.M., Meyer B.E., Simon J.H.M., Fischer U., Albright A.V., Gonzalez-Scarano F., Malim M.H. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J. Virol. 72:1998;6004-6013
28. Le Rouzic E., Mousnier A., Rustum C., Stutz F., Hallberg E., Dargemont C., Benichou S. Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1. J. Biol. Chem. 277:2002;45091-45098
29. Galimi F., Verma I.M. Opportunities for the use of lentiviral vectors in human gene therapy. Curr. Top. Microbiol. Immunol. 261:2002;245-254
30. Marshall E. Gene therapy. Second child in French trial is found to have leukemia. Science. 299:2003;320